Competitive macrophage microRNA-RNA binding protein interactions in wound repair
伤口修复中竞争性巨噬细胞 microRNA-RNA 结合蛋白相互作用
基本信息
- 批准号:9439844
- 负责人:
- 金额:$ 32.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAffinity ChromatographyAppearanceAreaAttentionBedsBindingBinding SitesBiological AssayBiotinBlood capillariesCellsChimeric ProteinsChronicComplexConsequentialismDefectDiabetes MellitusDorsalEarEconomic BurdenElderlyElementsExcisionFibroblastsGelatinase BGene ExpressionGenerationsGenesHealthHuR proteinImmuneIncidenceIndividualInflammationInflammatoryInflammatory ResponseInfluentialsInjuryInnate Immune ResponseIntegrinsKnockout MiceLuciferasesMediatingMediator of activation proteinMessenger RNAMicroRNAsModelingMolecularMorbidity - disease rateMultiple TraumaMusMyeloid CellsNatural ImmunityNatural regenerationOligonucleotidesOperative Surgical ProceduresPathway interactionsPhasePhenotypePlayPoriferaProcessProductionProteinsRNARNA-Binding ProteinsRecruitment ActivityReporterRibosomesRoleSiteSourceSurgical woundTherapeuticThickTissuesTranscriptTranscriptional ActivationTranscriptional RegulationTranslatingTranslationsUntranslated RegionsUrsidae FamilyVascular Endothelial Growth FactorsVenous InsufficiencyWidthWorkWound Healingaging populationcapillarychronic wounddiabeticeconomic costgene repairhealingimplantationimprovedinsightmRNA Transcript Degradationmacrophagemonocytemortalitynovelpre-clinicalprotective effectregenerativerepairedresponsetoolwound
项目摘要
Inadequate wound healing, resulting in chronic wounds, is a major and increasing U.S. health problem, due to
the rising incidence of diabetes and our aging population. Innate immune responses to tissue injury are critical
to wound repair. Monocyte/macrophages, both recruited and tissue-resident, secrete factors that are critical
mediators of the early proliferative and regenerative wound healing phases. Little attention has been paid to
posttranscriptional regulatory influences on gene expression in wound localized macrophages. This is a major
checkpoint in macrophage-dependent wound repair, since a majority of influential macrophage-derived
products are encoded by mRNAs that bear both AU-rich elements (AREs) and numerous microRNA (miRNA)
binding sites in their 3'-untranslated region (3'UTR). That is, a transcriptional activation trigger is often
insufficient for adequate gene expression. In particular, RNA-binding proteins (RBPs) protect vulnerable
3'UTRs from miRNA binding and consequent translational arrest (and/or mRNA degradation). We have
recently demonstrated that macrophage β2 integrin engagement results in dynamic modulation of the RBP
HuR, which protects numerous 3'UTR ARE-bearing mRNAs from degradation or translation blocks. We have
shown that macrophage HuR gene-deleted mice have repair defects in multiple wound models. In dynamic
fashion, HuR has the ability to relieve miRNA-mediated gene expression constraints. Our hypothesis is that
expression of a set of wound healing-promoting genes, both overlapping and distinct in recruited vs. tissue-
resident macrophages, is driven by HuR-dependent release of miRNA-mediated translation blocks. We have
generated unique, macrophage-specific translational profiling tools, and now propose to: (1) document the
presence of candidate, and define novel, macrophage mRNAs undergoing active, HuR-dependent translation
in early wound healing responses, using the Translating Ribosome Affinity Purification (TRAP) assay, with
pulldowns of the ribosomal fusion protein L10a-EGFP, expressed in myeloid cell-specific fashion, in HuR wild-
type or gene-deleted mice; (2) define miRNAs that target those TRAP-defined mRNAs, with biotin-3'UTR
riboprobe pulldowns of FACS-sorted L10a-EGFP+, wound localized macrophage extracts, confirming their
translation-repressing effects in dual luciferase 3'UTR reporter assays; and (3) release the miRNA-mediated
translational constraint on wound healing-promoting mRNAs, topically applying miRNA target site blocker
oligonucleotides which interfere with binding to specific mRNA 3'UTR target sites, in dorsal full thickness
excisional and ear punch hole wound models, assessing wound area, re-epithelialization, revascularization and
fibroblast repopulation. These molecular and preclinical approaches, directed at a gene expression regulatory
switch in wound-responsive macrophages, will provide mechanistic insight with therapeutic implications.
伤口愈合不充分导致慢性伤口是美国一个主要且日益严重的健康问题,原因是
糖尿病发病率的上升和人口老龄化对组织损伤的先天免疫反应至关重要。
单核细胞/巨噬细胞(无论是募集的还是组织驻留的)都分泌对伤口修复至关重要的因子。
早期增殖和再生伤口愈合阶段的介质很少受到关注。
转录后调控对伤口局部巨噬细胞基因表达的影响。
巨噬细胞依赖性伤口修复中的检查点,因为大多数有影响力的巨噬细胞衍生
产品由含有富含 AU 的元件 (ARE) 和大量 microRNA (miRNA) 的 mRNA 编码
其 3'-非翻译区 (3'UTR) 中的结合位点通常是转录激活触发器。
尤其是,RNA 结合蛋白 (RBP) 不足以保护脆弱的基因。
来自 miRNA 结合和随后的翻译停滞(和/或 mRNA 降解)的 3'UTR。
最近证明巨噬细胞 β2 整合素参与导致 RBP 的动态调节
HuR,它可以保护许多带有 3'UTR 的 mRNA 免遭降解或翻译阻断。
研究表明,巨噬细胞 HuR 基因缺失的小鼠在多个伤口模型中存在修复缺陷。
时尚的是,HuR 有能力缓解 miRNA 介导的基因表达限制。
一组促进伤口愈合的基因的表达,在募集和组织中既有重叠又有不同-
常驻巨噬细胞,是由 miRNA 介导的翻译块的 HuR 依赖性释放驱动的。
独特生成的巨噬细胞特异性翻译分析工具,现在建议:(1)记录
候选者的存在,并定义新的巨噬细胞 mRNA 正在经历活跃的 HuR 依赖性翻译
在早期愈合伤口反应中,使用翻译核糖体亲和纯化 (TRAP) 测定,
核糖体融合蛋白 L10a-EGFP 的下拉,以骨髓细胞特异性方式表达,在 HuR 野生中
类型或基因删除的小鼠;(2) 定义针对那些 TRAP 定义的 mRNA 的 miRNA,带有生物素-3'UTR
FACS 分选的 L10a-EGFP+、伤口局部巨噬细胞提取物的核糖探针下拉,证实了它们的
双荧光素酶 3'UTR 报告基因检测中的翻译抑制作用;以及 (3) 释放 miRNA 介导的
对伤口愈合促进 mRNA 的翻译限制,局部应用 miRNA 靶位点阻断剂
干扰与特定 mRNA 3'UTR 靶位点结合的寡核苷酸,位于背侧全层
切除和耳穿孔伤口模型,评估伤口面积、上皮再形成、血管重建和
这些分子和临床前方法针对基因表达调控。
伤口反应性巨噬细胞的转变将提供具有治疗意义的机制见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY R. BENDER其他文献
JEFFREY R. BENDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY R. BENDER', 18)}}的其他基金
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
- 批准号:
10761365 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasis
RNA靶位点寡核苷酸倾斜免疫细胞促进血管平滑肌细胞稳态
- 批准号:
10593490 - 财政年份:2022
- 资助金额:
$ 32.24万 - 项目类别:
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis
microRNA 靶位点 RNA 引导的寡核苷酸局部治疗银屑病
- 批准号:
10287633 - 财政年份:2021
- 资助金额:
$ 32.24万 - 项目类别:
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis
microRNA 靶位点 RNA 引导的寡核苷酸局部治疗银屑病
- 批准号:
10426347 - 财政年份:2021
- 资助金额:
$ 32.24万 - 项目类别:
Competitive macrophage microRNA-RNA binding protein interactions in wound repair
伤口修复中竞争性巨噬细胞 microRNA-RNA 结合蛋白相互作用
- 批准号:
10001549 - 财政年份:2017
- 资助金额:
$ 32.24万 - 项目类别:
Modulation neuroinflammation through interference of cooperative microRNA-RNA-binding protein interactions
通过干扰 microRNA-RNA 结合蛋白相互作用来调节神经炎症
- 批准号:
9300853 - 财政年份:2016
- 资助金额:
$ 32.24万 - 项目类别:
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development
GA 生物标志物开发中的 IFN-γ-整合素生长因子轴
- 批准号:
7491183 - 财政年份:2007
- 资助金额:
$ 32.24万 - 项目类别:
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development
GA 生物标志物开发中的 IFN-γ-整合素生长因子轴
- 批准号:
7297628 - 财政年份:2006
- 资助金额:
$ 32.24万 - 项目类别:
Imaging DTH, IFN gamma responses & GA in human arteries
成像 DTH、IFN γ 反应
- 批准号:
6659332 - 财政年份:2002
- 资助金额:
$ 32.24万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别: